Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors

Critical Care Explorations
Zekaver Odabasi, Ismail Cinel

Abstract

Taking into consideration the multisystemic clinical and autopsy findings in "severe" coronavirus disease 2019 patients, viral sepsis would be a more accurate term to describe the whole clinical picture. The most significant pathophysiological components of this picture are intense cytokine release, prolonged inflammation, immunosuppression with T cell exhaustion, and the development of organ dysfunctions. Currently, the optimal treatment for severe coronavirus disease 2019 is uncertain. Supportive treatment and immunomodulators have a critical place in the treatment of severe patients until effective antivirals are developed. Interleukin-6 antagonists, one of the immunomodulating agents, appears to be effective in the treatment of cytokine storm, but some patients continue to have severe lymphopenia and immunosuppression. We believe it can be useful as immunomodulator therapy in critical coronavirus disease 2019 patients because of the benefits of immune checkpoint inhibitors in cancer and sepsis patients.

References

Jan 29, 2002·Nature Immunology·Janice M MoserAron E Lukacher
Dec 4, 2008·Critical Care Medicine·Ismail Cinel, Steven M Opal
Jul 9, 2011·Nature Immunology·E John Wherry
Apr 26, 2014·Nature Reviews. Immunology·Akiko Iwasaki, Padmini S Pillai
Jul 23, 2014·Shock·Anne M DrewryRichard S Hotchkiss
Jan 21, 2016·Critical Care : the Official Journal of the Critical Care Forum·Andrej SpecRichard S Hotchkiss
Jan 25, 2017·Nature Reviews. Disease Primers·Richard S HotchkissJean-Louis Vincent
Feb 7, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Martin RaoMarkus Maeurer
Oct 16, 2018·Frontiers in Immunology·Gu-Lung LinAndrew J Pollard
Jan 20, 2019·Clinical Science·Jitwadee InthagardAntonia K Roseweir
Apr 18, 2019·Immunity·Sujin KangTadamitsu Kishimoto
Oct 19, 2019·Journal for Immunotherapy of Cancer·Thorbald van HallEric Vivier
Nov 18, 2019·Critical Care Clinics·Michelle E WakeleyAlfred Ayala
Feb 29, 2020·The New England Journal of Medicine·Wei-Jie GuanUNKNOWN China Medical Treatment Expert Group for Covid-19
Mar 20, 2020·JAMA : the Journal of the American Medical Association·Matt ArentzMelissa Lee
Mar 24, 2020·Cellular & Molecular Immunology·Meijuan ZhengZhigang Tian
Mar 27, 2020·The New England Journal of Medicine·Richard S Hotchkiss, Steven M Opal
Mar 29, 2020·The Journal of Clinical Investigation·Guang ChenQin Ning
Apr 1, 2020·Signal Transduction and Targeted Therapy·Li TanHongming Miao
Apr 1, 2020·The New England Journal of Medicine·Pavan K BhatrajuCarmen Mikacenic
Apr 2, 2020·Viruses·Yuefei JinGuangcai Duan
Apr 17, 2020·Signal Transduction and Targeted Therapy·Li TanHongming Miao
Apr 28, 2020·Clinical Drug Investigation·Shengyu ZhangZhigang Qi
May 1, 2020·Proceedings of the National Academy of Sciences of the United States of America·Xiaoling XuHaiming Wei
May 7, 2020·Annals of Internal Medicine·Dominic WichmannStefan Kluge

❮ Previous
Next ❯

Citations

Aug 25, 2020·Critical Care Medicine·Claire N ShappellChanu Rhee
Dec 29, 2020·Critical Care Explorations·John P DavisJ Randall Moorman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.